Complete profile
Last Updated: 2011-11-24
Biophage Pharma Inc.
Company information
|
|
||||
| Legal Name: Biophage Pharma Inc. | ||||
| Operating Name: Biophage Pharma Inc. | ||||
|
Mailing Address
6100 Royalmount Ave MONTRÉAL, Quebec H4P 2R2 |
Location Address
6100 Royalmount Ave MONTRÉAL, Quebec H4P 2R2 |
|||
| Telephone: (514) 496-1488 | ||||
| Toll Free Phone: 1-877-770-7773 | ||||
| Fax: (514) 496-1521 | ||||
| Email: info@biophagepharma.net | ||||
| Website URL: http://www.biophagepharma.net | ||||
Contact information
| Rosemonde Mandeville | ||
| Title: Chief Executive Officer | ||
| Area of Responsibility: Management Executive | ||
| Telephone: (514) 496-1488 | ||
| Fax: (514) 496-1521 | ||
| Email: rosemonde.mandeville@biophagepharma.net | ||
| Elie Farah | ||
| Title: Chief Operating Officer | ||
| Area of Responsibility: Domestic Sales & Marketing | ||
| Telephone: (514) 496-1488 | ||
| Fax: (514) 496-1521 | ||
Company description
|
Biophage Inc. is a privately held Montreal based
biopharmaceutical company founded in 1995 that discovers and develops proprietary therapeutic products for the treatment of inflammation in humans and bacterial infections in livestock and humans. Biophage technology platforms are based on the unique properties of phages and antibodies Biophage operates two divisions: (1) The R & D division and (2) The Contract Research Organization (CRO) division. Biophage R & D division develops the Company’s compounds with the objective of taking them to the market place or licensing them to Pharmaceutical companies once clear proof of concept has been established. Biophage CRO division supports biotech and pharma companies in their early drug development by providing In vitro and In vivo development services in the fields of immunology, infectiology and oncology. Biophage provides assistance and support in developing customized screens and experimental models tailored to meet its client’s specialized analytical requirements. The identity of clients and test results are handled under strict confidentiality. Our technical staff has extensive training and experience in: - Drug discovery and early stage drug development; - Molecular Biology services including mRNA protection assay, RT-PCR, 2-Hybrid system, - Custom antibody production, purification and antigenic prediction; - Immunoassay development (Elisa, RIA, etc); - Immunology and Immunotoxicology including 3-color Flow Cytometry, Cytokines, Effector cells evaluation - Cell culture testing (mycoplasma and sterility testing); - Phage display technologies and phage therapeutics - Immune Modulators and Anti-infectives activity testing - Development of mammalian and bacterial vectors Efficacy tests including: (i) immunology and immunotoxicology; (ii) in vitro and in vivo anti-tumor profiling using our panel of over 130 human and rodent cell lines; (iii) complete and integrated services of necropsy and histopathology; (iv) microbiological testing (bacteria, virus and fungi); and (v) pilot toxicological studies in rodents. Biophage Inc. senior management team has over 100 years of combined experience in business and technology development in health care and biotechnology industries. Biophage is led by Rosemonde Mandeville, M.D., Ph.D., (President, CEO & CSO). |
|
| Country of Ownership: | Canada |
| Year Established: | 1995 |
| Exporting: | Yes |
| Quality Certification: | ISO 9001 |
| Primary Industry (NAICS): | 541710 - Research and Development in the Physical, Engineering and Life Sciences |
| Primary Business Activity: | Manufacturer / Processor / Producer |
| Total Sales ($CDN): | $500,000 to $999,999 |
| Export Sales ($CDN): | $100,000 to $199,999 |
| Number of Employees: | 21 |
Product / Service / Licensing
| Service Name: |
Biotechnology |
|
| Service Name: |
Custom research services |
|
|
Biophage fully integrated CRO and R&D units offer:
- Custom research services for drug development and delivery. - Decapeptide libraries - Mycoplasma detection services. - Production, purification and characterization of polyclonal, monoclonal and recombinant antibodies. - Standardized in vito tests in haematology and toxicology. - Complete and integrated services for necropsy and histopathology. - A large battery of in vivo animal models in the area of oncology, immunology, infection and inflammation. |
||
Technology profile
Lisensed to exploit new, innovative and patented platformtechnologies in the health industry with specific focus on
cancer, infection/inflammation, and immune modulation. Using our
Ligand Discovery Technology (LTD), Biophage designs and produces
thousands of unique new compunds, reducing the cost and speeding
the process of drug discovery.
Market profile
Alliances:
- Financial
- Sales/Marketing
- Technology
Strategic alliances:
Biophage, is actively seeking to establish strategic allianceswith credible companies that share our values and commitment and
whose strengths are complementary in order to broaden the range
of opportunities and build together a stronger business.Fields
of interest: animal health, infection, inflammation, cancer.
Industry sector market interests:
- Medical/Biotechnology/Chemical
Geographic markets:
Actively pursuing:
- California
- Michigan
- Missouri
Sector information
Unique applications:
Key / Major clients:
Success stories:
Testimonial:
Note: This document is presented in the language provided by the author/source. Most of the information contained in Canadian Company Capabilities (CCC) has been provided by sources external to Industry Canada. The accuracy, currency and reliability of the information contained in CCC are the sole responsibility of the registered companies and related organizations. Industry Canada assumes no responsibility in this respect. The registered businesses shall ensure the continued monitoring of the information contained in CCC and ask that it be modified when necessary.
-
Date Modified: 2013-05-18
